Promoted growth of murine hair follicles through controlled release of vascular endothelial growth factor.
The objective of this study is to investigate whether or not the controlled release of vascular endothelial growth factor (VEGF) is effective in promoting the hair follicle growth of mice in second anagen of hair cycle. VEGF was incorporated into a biodegradable collagen hydrogel for its controlled release. Following implantation of the collagen hydrogel incorporating 0 or 2 microg of VEGF and injection of 0 or 2 microg of VEGF in the solution form into the back subcutis of mice, the hair follicle growth was evaluated photometrically and histologically in terms of the skin color of reverse side of the implanted or injected site, the skin thickness, and the area occupied by hair follicle tissue. Ten days later, the skin color of mice implanted with the collagen hydrogel incorporating 2 microg of VEGF was significantly darker than that injected with 2 pg of VEGF. The collagen hydrogel incorporating VEGF increased the hair follicle area at the implanted site to a significantly greater extent than other agents while significant angiogenetic effect in the skin tissue was observed. VEGF-free, empty collagen hydrogels did not affect the skin darkness, hair follicle growth, and the angiogenesis. Moreover, the hair shaft length was significantly elongated by the collagen hydrogel incorporating VEGF, in marked contrast to other agents. Immunohistolchemicalstaining with proliferating cell nuclear antigen revealed that the collagen hydrogel incorporating VEGF promoted the proliferation of cells around the hair follicle more frequently than free VEGF. We concluded that the controlled release of VEGF more positively acted on the hair growth cycle of mice for hair growth than the injection of free VEGF.
Ozeki
Makoto
M
Institute for Frontier Medical Sciences, Kyoto University, Japan.
Tabata
Yasuhiko
Y
D000818:Animals; D003094:Collagen; D003692:Delayed-Action Preparations; D016228:Endothelial Growth Factors / Q000008:administration & dosage*; D018859:Hair Follicle / Q000187:drug effects* / Q000254:growth & development* / Q000378:metabolism; D006801:Humans; D020100:Hydrogels; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage*; D008222:Lymphokines / Q000008:administration & dosage*; D008297:Male; D008422:Materials Testing; D051379:Mice; D008809:Mice, Inbred C3H; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D011994:Recombinant Proteins / Q000008:administration & dosage; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D003692:Delayed-Action Preparations; D016228:Endothelial Growth Factors; D020100:Hydrogels; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D018809:Proliferating Cell Nuclear Antigen; D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D003094:Collagen